AI · Machine Learning · Deep Learning · Cybersecurity — in Healthcare. Backing pre-seed and seed founders building what the industry needs most.
Tarralake is a Delaware-based family investment fund with a singular thesis: AI · Machine Learning · Deep Learning · Cybersecurity — applied to Healthcare.
We back early-stage founders building technology that makes healthcare smarter, safer, and more secure. We move with conviction, take fewer positions, and go deeper with every founder we back.
Minimum check size is $50,000. We invest at pre-seed and seed stage.
Beyond traditional deal flow, Tarralake actively identifies exceptional technical founders emerging from premier academic institutions and incubators worldwide — bringing breakthrough ideas in AI and cybersecurity to the US healthcare market.
Built by a founder who has done it — from zero to a successful exit. We understand what founders need because we have lived it.
AI, ML, Deep Learning, and Cybersecurity in healthcare only. Deep expertise, not a scattered approach.
Family fund structure means no LP pressure and no artificial timelines. We invest with patience and stay committed through the journey.
Delaware LLC. Standard agreements. No complications for founders.
We invest exclusively at the intersection of healthcare and deep technology — where AI, Deep Learning, Machine Learning, and Cybersecurity are transforming how care is delivered, diagnosed, secured, and understood.
Clinical decision support, diagnostics, and care automation. We back AI that makes clinicians faster and patients safer.
Medical imaging, radiology AI, pathology, and genomics. Neural networks transforming clinical diagnosis at the frontier of what machines can see.
Predictive analytics, health data infrastructure, and population health intelligence. Turning complexity into clinical insight.
Patient data protection, ransomware defense, and identity security for health systems. The most targeted sector — and the least protected.
Ph.D. and founder of Hirezon Corporation (2002–2025), a SaaS HR platform acquired by Embrace Software (Inc. 5000). Now investing in healthcare technology — AI · Machine Learning · Deep Learning · Cybersecurity — through Tarralake.
Dr. Viswanathan is supported by a network of seasoned advisors across healthcare, technology, and investment — bringing clinical credibility, operational expertise, and institutional relationships to every investment Tarralake makes.
Senior executives and clinical leaders from health systems, hospital networks, and digital health companies who understand what healthcare organizations actually buy and deploy.
Experienced founders and engineers in AI, deep learning, cybersecurity, and SaaS — who have built and scaled technology platforms from inception to exit.
Investors with deep experience in healthcare technology, life sciences, and early-stage venture — bringing pattern recognition and co-investment relationships.
Advisor details will be announced at launch in July 2026. If you are a healthcare operator, technology executive, or investor interested in joining the Tarralake advisory network, please reach out.
Get Involved →Tarralake is building an advisory network of experienced professionals who want to help shape the future of healthcare technology investing. If that's you — we'd love to hear from you.
Access to curated deal flow, co-investment opportunities, and a seat at the table shaping healthcare's most important technology bets.
Clinical leaders, health system executives, AI/cybersecurity founders, and investors with a track record in healthcare technology.
Thank you for your interest in the Tarralake advisory network. We will be in touch ahead of our July 2026 launch.
We are currently reviewing pitch decks in preparation for our July 2026 opening.
Register now to be among the first founders considered.
Tarralake will begin deploying capital in July 2026. Submit your details now and we will review your deck ahead of our opening. Pre-seed and seed stage only. Minimum check: $50,000. All submissions are reviewed personally by Dr. Naray Viswanathan.